Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Hidratos de carbono, metabolismo de la glucosa y cáncer
Información de la revista
Vol. 53. Núm. 4.
Páginas 252-255 (Abril 2006)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 53. Núm. 4.
Páginas 252-255 (Abril 2006)
Revisiones
Acceso a texto completo
Hidratos de carbono, metabolismo de la glucosa y cáncer
Carbohydrates, glucose metabolism and cancer
Visitas
...
J. Pérez-Guisado??
Autor para correspondencia
pv1peguj@uco.es

Correspondencia: Dr. J. Pérez-Guisado. Don Lope de Sosa, 37, escalera izquierda, 2.° A. 14004 Córdoba. España.
Departamento de Medicina. Facultad de Medicina. Universidad de Córdoba. Córdoba. España
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas

Hay multitud de estudios epidemiológicos que asocian el consumo de dietas ricas en productos de origen animal con la génesis del cáncer, pero que no tienen en cuenta, a la hora de recoger y analizar los datos, el efecto que pudieran tener los hidratos de carbono de la dieta y las alteraciones presentes en el metabolismo de la glucosa, que pueden ser importantes sesgos de confusión. Esto se debe a que se ha comprobado que factores relacionados con los hidratos de carbono y el metabolismo de la glucosa, como la contribución energética de los hidratos de carbono, el índice glucémico y la carga glucémica de los alimentos ingeridos así como la glucemia y la insulinemia, tanto en ayunas como tras una sobrecarga oral con glucosa, pueden estar asociados al riesgo de desarrollar muchos tipos de cáncer, por lo que deberían tenerse en cuenta en la recogida e interpretación de la información epidemiológica.

Palabras clave:
Cáncer
Tumor
Dieta
Hidratos de carbono
Glucosa
Índice glucémico
Carga glucémica
Insulina
Resistencia insulínica
IGF-1

Many epidemiological studies have linked a high intake of animal products with the genesis of cancer. However, when collecting and analyzing data, these studies do not take into account the possible effects of dietary carbohydrates and glucose metabolism abnormalities, which are important confounding variables that could be important diases. Factors related to carbohydrates and glucose metabolism, such as the energetic contribution of carbohydrates, the glycemic index and glycemic load, fasting glycemia and insulinemia, as well as glucose and insulin levels after oral glucose load, are associated with the risk of developing many types of cancer. Therefore, these factors should be kept in mind when collecting and interpreting epidemiologic information.

Key words:
Cancer
Tumor
Diet
Carbohydrates
Glucose
Glycemic index
Glycemic load
Insulin
Insulin resistance
IGF-1
El Texto completo está disponible en PDF
Bibliografía
[1.]
V.M. Macaulay.
Insulin-like growth factors and cancer.
Br J Cancer, 65 (1992), pp. 311-320
[2.]
K. Oku, A. Tanaka, H. Yamanishi, Y. Nishizawa, K. Matsumoto, H. Shiozaki, et al.
Effects of various growth factors on growth of a cloned human esophageal squamous cancer cell line in a protein-free medium.
Anticancer Res, 11 (1991), pp. 1591-1595
[3.]
D. LeRoith, R. Baserga, L. Helman, C.T. Roberts Jr.
Insulin-like growth factors and cancer.
Ann Intern Med, 122 (1995), pp. 54-59
[4.]
Y. Yaginuma, K. Nishiwaki, S. Kitamura, H. Hayashi, K. Sengoku, M. Ishikawa.
Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors.
Oncology, 54 (1997), pp. 502-507
[5.]
P. Singh, B. Dai, U. Yallampalli, X. Lu, P.C. Schroy.
Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II.
Endocrinology, 137 (1996), pp. 1764-1774
[6.]
S. Frostad, O. Bruserud.
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts.
Eur J Haematol, 62 (1999), pp. 191-198
[7.]
D.K. Snyder, D.R. Clemmons, L.E. Underwood.
Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
J Clin Endocrinol Metab, 69 (1989), pp. 745-752
[8.]
J.R. Florini, D.Z. Ewton, K.A. Magri.
Hormones, growth factors, and myogenic differentiation.
Annu Rev Physiol, 53 (1991), pp. 201-216
[9.]
H.D. Strickler, J. Wylie-Rosett, T. Rohan, D.R. Hoover, S. Smoller, R.D. Burk, et al.
The relation of type 2 diabetes and cancer.
Diabetes Technol Ther, 3 (2001), pp. 263-274
[10.]
F.S. Facchini, N. Hua, F. Abbasi, G.M. Reaven.
Insulin resistance as a predictor of age-related disease.
J Clin Endocrinol Metabol, 86 (2001), pp. 3574-3578
[11.]
S.H. Jee, H. Ohrr, J.W. Sull, J.E. Yun, M. Ji, J.M. Samet.
Fasting serum glucose level and cancer risk in Korean men and women.
J Am Med Assoc, 293 (2005), pp. 235-236
[12.]
S.H. Saydah, C.M. Loria, M.S. Eberhardt, F.L. Brancati.
Abnormal glucose tolerance and the risk of cancer death in the United States.
Am J Epidemiol, 157 (2003), pp. 1092-1100
[13.]
L.S. Augustin, S. Gallus, C. Bosetti, F. Levi, E. Negri, S. Franceschi, et al.
Glycemic index and glycemic load in endometrial cancer.
Int J Cancer, 105 (2003), pp. 404-407
[14.]
A.R. Folsom, Z. Demissie, L. Harnack.
Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa Women's Health Study.
Nutr Cancer, 46 (2003), pp. 119-124
[15.]
S. Liu, W.C. Willett, M.J. Stampfer, F.B. Hu, M. Franz, L. Sampson, et al.
A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women.
Am J Clin Nutr, 71 (2000), pp. 1455-1461
[16.]
L.S. Augustin, J. Polesel, C. Bosetti, C.W. Kendall, C. La Vecchia, M. Parpinel, et al.
Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy.
Ann Oncol, 14 (2003), pp. 78-84
[17.]
M.D. Holmes, G.A. Colditz, D.J. Hunter, S.E. Hankinson, B. Rosner, F.E. Speizer, et al.
Meat, fish and egg Intake and risk of breast cancer.
Int J Cancer, 104 (2003), pp. 221-227
[18.]
N. Potischman, R.J. Coates, C.A. Swanson, R.J. Carroll, J.R. Daling, D.R. Brogan, et al.
Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States.
Cancer Causes Control, 13 (2002), pp. 937-946
[19.]
S. Franceschi, A. Favero, A. Decarli, E. Negri, C. La Vecchia, M. Ferraroni, et al.
Intake of macronutrients and risk of breast cancer.
Lancet, 347 (1996), pp. 1351-1356
[20.]
L.S. Augustin, L. Dal Maso, C. La Vecchia, M. Parpinel, E. Negri, S. Vaccarella, et al.
Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study.
Ann Oncol, 12 (2001), pp. 1533-1538
[21.]
P.J. Goodwin, M. Ennis, K.I. Pritchard, M.E. Trudeau, J. Koo, Y. Madarnas, et al.
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.
J Clin Oncol, 20 (2002), pp. 42-51
[22.]
I. Romieu, E. Lazcano-Ponce, L.M. Sánchez-Zamorano, W. Willet, M. Hérnandez-Ávila.
Carbohydrates and the risk of breast cancer among Mexican women.
Cancer Epidemiol Biomarkers Prev, 13 (2004), pp. 1283-1289
[23.]
S. Higginbotham, Z.F. Zhang, I.M. Lee, N.R. Cook, J.E. Buring, S. Liu.
Dietary glycemic load and breast cancer risk in the Women's Health Study.
Cancer Epidemiol Biomarkers Prev, 13 (2004), pp. 65-70
[24.]
L.S. Augustin, S. Gallus, E. Negri, C. La Vecchia.
Glycemic index, glycemic load and risk of gastric cancer.
Ann Oncol, 15 (2004), pp. 581-584
[25.]
H.B. El-Serag, T. Tran, J.E. Everhart.
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.
Gastroenterol, 126 (2004), pp. 460-468
[26.]
D.S. Michaud, S. Liu, E. Giovannucci, W.C. Willett, G.A. Colditz, C.S. Fuchs.
Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study.
J Natl Cancer Inst, 94 (2002), pp. 1293-1300
[27.]
M.J. Borugian, S.B. Sheps, A.S. Whittemore, A.H. Wu, J.D. Potter, R.P. Gallagher.
Carbohydrates and colorectal cancer risk among chinese in North America.
Cancer Epidemiol Biomarkers Prev, 11 (2002), pp. 187-193
[28.]
S. Franceschi, L. Dal Maso, L. Augustin, E. Negri, M. Parpinel, P. Boyle, et al.
Dietary glycemic load and colorectal cancer risk.
Ann Oncol, 12 (2001), pp. 173-178
[29.]
T.I. Nilsen, L.J. Vatten.
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis.
Br J Cancer, 84 (2001), pp. 417-422
[30.]
R.E. Schoen, C.M. Tangen, L.H. Kuller, G.L. Burke, M. Cushman, R.P. Tracy, et al.
Increased blood glucose and insulin, body size, and incident colorectal cancer.
J Natl Cancer Inst, 91 (1999), pp. 1147-1154
[31.]
W.R. Bruce, T.M. Wolever, A. Giacca.
Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.
Nutr Cancer, 37 (2000), pp. 19-26
[32.]
L.A. Colangelo, S.M. Gapstur, P.H. Gann.
Colorectal cancer mortality and factors related to the insulin resistance syndrome.
Cancer Epidemiol Biomarkers Prev, 11 (2001), pp. 385-391
[33.]
T.T. Tran, A. Medline, W.R. Bruce.
Insulin promotion of colon tumors in rats.
Cancer Epidemiol Biomarkers Prev, 5 (1996), pp. 1013-1015
[34.]
S. Franceschi, A. Favero, C. La Vecchia, E. Negri, E. Conti, M. Montella, et al.
Food groups and risk of colorectal cancer in Italy.
Int J Cancer, 72 (1997), pp. 56-61
[35.]
L.C. Nebeling, E. Lerner.
Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer.
J Am Diet Assoc, 95 (1995), pp. 693-697
[36.]
L.C. Nebeling, F. Miraldi, S.B. Shurin, E. Lerner.
Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.
J Am Coll Nutr, 14 (1995), pp. 202-208
[37.]
S.A. Beck, M.J. Tisdale.
Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice.
Cancer Res, 49 (1989), pp. 3800-3804
[38.]
P. Mukherjee, M.M. El Abbadi, J.L. Kasperzyk, M.K. Ranes, T.N. Seyfried.
Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.
Br J Cancer, 86 (2002), pp. 1615-1621
Copyright © 2006. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos